NCT00350454View on ClinicalTrials.gov

Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)

PHASE4CompletedINTERVENTIONAL
Enrollment

605

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

October 31, 2007

Conditions
Coronary Heart Disease
Interventions
DEVICE

rapamycin-eluting Stent with permanent polymer

due to randomization, rapamycin-eluting stent with permanent polymer will be implanted

DEVICE

rapamycin-eluting stent with biodegradable polymer

due to randomization, rapamycin-eluting stent with biodegradable polymer will be implanted

DEVICE

polymer-free, rapamycin-eluting stent

due to randomization, polymer-free.rapamycin-eluting stent will be implanted

Trial Locations (2)

80636

Deutsches Herzzentrum Muenchen, Munich

81675

1. Medizinische Klinik, Klinikum rechts der Isar, München

All Listed Sponsors
lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00350454 - Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3) | Biotech Hunter | Biotech Hunter